Advanced Solutions for Retinal Vascular Diseases: Achieving Superior Outcomes with Durable Treatments

The panel concludes its discussion with thoughts on the profound impact durable treatments have on the quality of life of patients with retinal diseases.

Expert retina speclialists discuss evolving treatment paradigms and the role of intravitreal steroids and macular laser for treating diabetic macular edema.

Greg Budoff, MD, presents the case of a patient with diabetic macular edema who achieved extended treatment interval, and the panel discusses treatment considerations, including the role of PRN regimens.

Katherine Talcott, MD, presents the case of a patient with diabetic macular edema, and the rest of the panel share their clinical experiences and discuss factors that inform the utilization of more durable agents.

Jaclyn Kovach, MD, FASRS, presents the case of a patient with neovascular AMD with persistent subretinal fluid, and members of the panel share their experiences treating similar patients.

Adiel Smith, MD, FASRS, presents the case of a patient with neovascular age-related macular degeneration (nAMD) with treatment-resistant pigment epithelium detachment, and the panel offers clinical insights on treatment decisions.